The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disp... ( New Alliance Aims to Reduce Dispariti...)

The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disparity Gaps

Date:2/25/2009

New Alliance Aims to Reduce Disparities in Diabetes Prevention and Management Among Most At-Risk Populations

WASHINGTON, Feb. 25 /PRNewswire-USNewswire/ -- The Merck Company Foundation (Foundation), the philanthropic arm of Merck & Co., Inc., today announced the launch of The Alliance to Reduce Disparities in Diabetes (Alliance), a new initiative designed to improve healthcare delivery among those populations most at risk for diabetes -- African-American, Hispanic, and Native American adults. The U.S. Department of Health and Human Services' Centers for Disease Control and Prevention (CDC) and the Office of Minority Health (OMH) joined the Foundation in support of the Alliance's goal to mobilize community-based partners and enhance the delivery of proven, collaborative approaches that can close gaps in diabetes care.

Research shows insufficient health resources, poor disease management, inadequate patient education and support, and individual perceptions about how difficult it is to manage and prevent diabetes all contribute to healthcare disparities. These problems are more acute in low-income, disadvantaged communities. To help enhance care and reduce disparities, the Alliance will support proven, community-based and collaborative approaches to comprehensive diabetes prevention and management. The initiative will engage a range of healthcare stakeholders, including patients, providers and health system leaders, to assist at the grassroots level in five U.S. communities and mobilize additional allies at the national and state levels.

"We cannot and should not ignore the growing physical and economic toll of inadequate healthcare on the lives of many individuals in the United States," said Richard T. Clark, chairman, president, and chief executive officer, Merck & Co., Inc. "Innovative, community-based programs are making real progress reducing the critical gaps in care that are so difficult for
'/>"/>

0

GOOD

Page: 1 2 3 4 5 6
Related medicine news :

1. Arena Pharmaceuticals Announces Initiation by Merck of Phase 2 Clinical Trial of Niacin Receptor Agonist
2. Drugs from Biogen Idec and Merck are the Most Promising Therapies in Development in the Acute Heart Failure Market
3. Merck Serono and Apitope Announce Licensing Agreement on Novel Peptide Therapeutics for the Treatment of Multiple Sclerosis
4. Clarus Ventures Hires Former Merck President Ed Scolnick and Broad Institute Scientist Finny Kuruvilla
5. ARVO Foundation and Merck to provide prestigious global ophthalmic research award
6. Prasco to Distribute Generic Forms of Dorzolamide Hydrochloride-Timolol Maleate and Dorzolamide Hydrochloride Ophthalmic Solutions (Comparable to Mercks COSOPT(R) and TRUSOPT(R) Ophthalmic Solutions)
7. Merck KGaA and Nano-Terra Announce Extension of Nanotechnology Solutions Alliance
8. Mercks odanacatib increased BMD over 2 years at key fracture sites in Phase IIB study
9. Covance Recognized for Outstanding Performance by Merck & Co., Inc.
10. Schering-Plough and Merck Announce Withdrawal of Loratadine/Montelukast NDA and Termination of Respiratory Joint Venture
11. Schiffrin Barroway Topaz & Kessler, LLP Announces Court Ruling Relating to Merck & Co. Inc.s Employee Savings & Security Plan, the Merck & Co., Inc. Employee Stock Purchase & Savings Plan, and the Merck Puerto Rico Employee Savings & Security Plan

Post Your Comments:

The Merck Company Foundation Launches Five-Year Effort to Close Healthcare Disp...( New Alliance Aims to Reduce Dispariti...),Health